世界の鉄欠乏性貧血(IDA)治療市場(2023-2030):治療種類別(経口鉄剤治療、非経口鉄剤治療)、年齢層別、エンドユーザー別、地域別

【英語タイトル】Iron Deficiency Anemia Therapy Market Size, Share & Trends Analysis Report By Therapy Type (Oral Iron Therapy, Parenteral Iron Therapy), By Age Group, By End-user, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料(GRV23NOV276)・商品コード:GRV23NOV276
・発行会社(調査会社):Grand View Research
・発行日:2023年9月
・ページ数:120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,360,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

鉄欠乏性貧血(IDA)治療市場の成長と動向
鉄欠乏性貧血(IDA)治療の世界市場規模は、2030年までに80億6000万米ドルに達する見込みであることが、Grand View Research, Inc. 2023年から2030年までの年平均成長率は7.6%と予測されています。月経時の異常多量出血や分娩後出血の症例が増加していることが、若い女性におけるIDA療法の採用率を高めている主な要因です。さらに、女性の栄養健康に対する意識の高まり、非経口栄養サプリメントの進歩、新規製品の発売は、鉄欠乏性貧血(IDA)治療市場の成長を促進するいくつかの主要なドライバーです。

2023年3月に更新された国立医学図書館の報告書によると、月経困難症の年間有病率は女性1,000人当たり53人です。また、2018年6月に国立医学図書館が発表した別の論文によると、更年期世代におけるIDA症例の約5~10%は、月経痛(月経血量が多い)などの月経障害が寄与しているとのことです。さらに、栄養鉄欠乏症が更年期女性の間ですでに蔓延している発展途上国では、月経困難症が悪化因子となり、重度の貧血を引き起こします。

女性の栄養健康に対する人々の意識の高まりや地域政府による戦略的イニシアティブ、非経口栄養サプリメントの進歩、新規製品の発売は、世界のIDA療法市場成長の主な推進要因の一部です。例えば、インドでは2023年2月にケララ州政府が、中央政府の貧血予防プログラム(Anaemia Mukt Bharat program)に加えて、イニシアチブを開始しました。このキャンペーンは、6ヵ月以内に州全体で約1,300万人の女性にリーチすることを目標に実施されました。貧血の負担を軽減するための段階的な介入策をテストし実施するため、戸別訪問キャンペーンが実施されました。

業界大手は製品ポートフォリオを強化するため、提携や買収を進めています。例えば、2022年11月、CSL ViforとFresenius Kabiは、静脈内鉄療法であるFerinjectが成人患者の鉄欠乏症治療薬として中国のNMPAから承認を取得したと発表しました。フェリンジェクトの適応は、経口製剤が無効または不適当な場合、あるいは臨床的に迅速な鉄投与が必要な場合。当時、両社は2023年前半にフェリンジェクトの販売を開始する予定であり、今回の承認により85カ国で販売承認を取得し、2024年1月にはNRDLへの上場を予定していました。これにより、市場でのプレゼンスが向上し、患者さんのフェリンジェクトへのアクセスが世界的に拡大することになります。同様に、サンドは2021年7月、鉄欠乏性貧血(IDA)治療薬として初の高用量静注用鉄のジェネリック医薬品である、費用対効果の高いフェルモキシトール注射剤を米国で発売しました。

鉄欠乏性貧血(IDA)治療市場レポートハイライト

- 鉄欠乏性貧血(IDA)治療市場全体の成長は、世界中で鉄欠乏に伴う貧血の有病率が増加していることに起因します。

- 市場は、特に慢性または重症度の低い鉄欠乏性貧血(IDA)患者にとって魅力的な在宅医療環境に対する嗜好の高まりという重要な変化を目の当たりにしています。

- 非経口鉄剤療法が2022年に最も大きなシェアを占めました。これは、非経口鉄剤の進歩や市場に参入している主要企業による新製品の発売によるものです。

- 成人年齢層セグメントは2022年に63.87%の最大売上シェアを占めました。これは、多忙なライフスタイルや不適切な食生活が成人の鉄欠乏性貧血(IDA)の広範な有病率に寄与しているためです。

- 北米は、複数の主要企業の存在と、同地域における鉄欠乏性貧血(IDA)の負担を克服するための政府からの支援の高まりにより、2022年の市場を支配しました。

- 同市場の主要企業は、新製品発売、パートナーシップ、提携などの戦略を採用し、世界的な地域拡大を図っています。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. 市場変動・動向・範囲
第4章. 世界の鉄欠乏性貧血(IDA)治療市場:治療タイプ別予測・動向分析
第5章. 世界の鉄欠乏性貧血(IDA)治療市場:年齢層別予測・動向分析
第6章. 世界の鉄欠乏性貧血(IDA)治療市場:エンドユーザー別予測・動向分析
第7章. 世界の鉄欠乏性貧血(IDA)治療市場:地域別予測・動向分析
第8章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation And Scope
1.1.1. Segment Definitions
1.1.1.1. Therapy Type Segment
1.1.1.2. Age Group Segment
1.1.1.3. End-User Segment
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective – 1
1.4.2. Objective – 2
1.4.3. Objective – 3
1.5. Research Methodology
1.6. Information Or Data Analysis
1.7. Market Model
1.7.1. Commodity Flow Analysis
1.8. List Of Secondary Sources
1.9. List Of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Therapy Type and Age Group Snapshot
2.3. End-user Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing global elderly population
3.2.1.2. Increasing prevalence of iron deficiency anemia
3.2.1.3. Growing government initiatives to overcome the burden of iron deficiency
3.2.2. Market Restraint Analysis
3.2.2.1. Side effects associated with certain IDA therapies
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Therapy Type Business Analysis
4.1. Iron Deficiency Anemia Therapy Market: Therapy Type Movement Analysis
4.2. Oral Iron Therapy
4.2.1. Oral Iron Therapy Market, 2018 – 2030 (USD Million)
4.3. Parenteral Iron Therapy
4.3.1. Parenteral Iron Therapy Market, 2018 – 2030 (USD Million)
4.4. Red Blood Cell Transfusion
4.4.1. Red Blood Cell Transfusion Market, 2018 – 2030 (USD Million)
4.5. Others
4.5.1. Others Market, 2018 – 2030 (USD Million)
Chapter 5. Age Group Business Analysis
5.1. Iron Deficiency Anemia Therapy Market: Age Group Movement Analysis
5.2. Adults
5.2.1. Adults Market, 2018 – 2030 (USD Million)
5.3. Pediatric
5.3.1. Pediatric Market, 2018 – 2030 (USD Million)
5.4. Geriatric
5.4.1. Geriatric Market, 2018 – 2030 (USD Million)
Chapter 6. End-User Business Analysis
6.1. Iron Deficiency Anemia Therapy Market: End-User Movement Analysis
6.2. Clinics
6.2.1. Clinics Market, 2018 – 2030 (USD Million)
6.3. Hospitals
6.3.1. Hospitals Market, 2018 – 2030 (USD Million)
6.4. Home Healthcare
6.4.1. Home Healthcare Market, 2018 – 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. Iron Deficiency Anemia Therapy Market Share By Region, 2022 & 2030
7.2. North America
7.2.1. SWOT Analysis
7.2.2. North America Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.2.3. U.S.
7.2.3.1. Key Country Dynamics
7.2.3.2. Target Disease Prevalence
7.2.3.3. Competitive Scenario
7.2.3.4. Regulatory Framework
7.2.3.5. U.S. Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.2.4. Canada
7.2.4.1. Key Country Dynamics
7.2.4.2. Target Disease Prevalence
7.2.4.3. Competitive Scenario
7.2.4.4. Regulatory Framework
7.2.4.5. Canada Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.3. Europe
7.3.1. Europe Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Target Disease Prevalence
7.3.2.3. Competitive Scenario
7.3.2.4. Regulatory Framework
7.3.2.5. UK Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Target Disease Prevalence
7.3.3.3. Competitive Scenario
7.3.3.4. Regulatory Framework
7.3.3.5. Germany Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Target Disease Prevalence
7.3.4.3. Competitive Scenario
7.3.4.4. Regulatory Framework
7.3.4.5. France Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Target Disease Prevalence
7.3.5.3. Competitive Scenario
7.3.5.4. Regulatory Framework
7.3.5.5. Italy Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Target Disease Prevalence
7.3.6.3. Competitive Scenario
7.3.6.4. Regulatory Framework
7.3.6.5. Spain Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Target Disease Prevalence
7.3.7.3. Competitive Scenario
7.3.7.4. Regulatory Framework
7.3.7.5. Denmark Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Target Disease Prevalence
7.3.8.3. Competitive Scenario
7.3.8.4. Regulatory Framework
7.3.8.5. Sweden Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Target Disease Prevalence
7.3.9.3. Competitive Scenario
7.3.9.4. Regulatory Framework
7.3.9.5. Norway Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Competitive Scenario
7.4.2.4. Regulatory Framework
7.4.2.5. Japan Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Competitive Scenario
7.4.3.4. Regulatory Framework
7.4.3.5. China Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Competitive Scenario
7.4.4.4. Regulatory Framework
7.4.4.5. India Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Target Disease Prevalence
7.4.5.3. Competitive Scenario
7.4.5.4. Regulatory Framework
7.4.5.5. Australia Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Target Disease Prevalence
7.4.6.3. Competitive Scenario
7.4.6.4. Regulatory Framework
7.4.6.5. Thailand Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Target Disease Prevalence
7.4.7.3. Competitive Scenario
7.4.7.4. Regulatory Framework
7.4.7.5. South Korea Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Competitive Scenario
7.5.2.4. Regulatory Framework
7.5.2.5. Brazil Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Competitive Scenario
7.5.3.4. Regulatory Framework
7.5.3.5. Mexico Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Competitive Scenario
7.5.4.4. Regulatory Framework
7.5.4.5. Argentina Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.6. MEA
7.6.1. MEA Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Competitive Scenario
7.6.2.4. Regulatory Framework
7.6.2.5. South Africa Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Competitive Scenario
7.6.3.4. Regulatory Framework
7.6.3.5. Saudi Arabia Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Competitive Scenario
7.6.4.4. Regulatory Framework
7.6.4.5. UAE Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Competitive Scenario
7.6.5.4. Regulatory Framework
7.6.5.5. Kuwait Iron Deficiency Anemia Therapy Market, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Categorization
8.2. Strategy Mapping
8.2.1. New Product Launch
8.2.2. Partnerships
8.2.3. Collaboration
8.3. Key Company Market Share Analysis, 2022
8.4. Company Profiles
8.4.1. Akebia Therapeutics, Inc.
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Bayer AG
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. PHARMACOSMOS A/S
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Sanofi
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Johnson & Johnson Services, Inc.
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. CSL Vifor
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. AbbVie Inc. (Allergan)
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. Novartis AG
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Teoxane
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Zydus Group
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
8.4.11. GSK plc
8.4.11.1. Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Strategic Initiatives
8.4.12. AdvaCare Pharma
8.4.12.1. Overview
8.4.12.2. Financial Performance
8.4.12.3. Product Benchmarking
8.4.12.4. Strategic Initiatives
8.4.13. Apotex Inc.
8.4.13.1. Overview
8.4.13.2. Financial Performance
8.4.13.3. Product Benchmarking
8.4.13.4. Strategic Initiatives
8.4.14. Covis Pharma GmbH
8.4.14.1. Overview
8.4.14.2. Financial Performance
8.4.14.3. Product Benchmarking
8.4.14.4. Strategic Initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Iron Deficiency Anemia Therapy Market, By Therapy Type, 2018 - 2030 (USD Million)
Table 4 Global Iron Deficiency Anemia Therapy Market, By Age Group, 2018 - 2030 (USD Million)
Table 5 Global Iron Deficiency Anemia Therapy Market, By End-User, 2018 - 2030 (USD Million)
Table 6 Global Iron Deficiency Anemia Therapy Market, By Region, 2018 - 2030 (USD Million)
Table 7 North America Iron Deficiency Anemia Therapy Market, By Country, 2018 - 2030 (USD Million)
Table 8 North America Iron Deficiency Anemia Therapy Market, By Therapy Type, 2018 - 2030 (USD Million)
Table 9 North America Iron Deficiency Anemia Therapy Market, By Age Group, 2018 - 2030 (USD Million)
Table 10 North America Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 11 US Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 12 US Iron Deficiency Anemia Therapy Market, By Age Group, 2018 - 2030 (USD Million)
Table 13 US Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 14 Canada Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 15 Canada Iron Deficiency Anemia Therapy Market, By Age Group, 2018 - 2030 (USD Million)
Table 16 Canada Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 17 Europe Iron Deficiency Anemia Therapy market, by Country, 2018 - 2030 (USD Million)
Table 18 Europe Iron Deficiency Anemia Therapy Market, By Age Group, 2018 - 2030 (USD Million)
Table 19 Europe Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 20 Europe Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 21 UK Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 22 UK Iron Deficiency Anemia Therapy Market, By Age Group, 2018 - 2030 (USD Million)
Table 23 UK Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 24 Germany Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 25 Germany Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 26 Germany Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 27 France Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 28 France Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 29 France Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 30 Italy Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 31 Italy Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 32 Italy Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 33 Spain Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 34 Spain Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 35 Spain Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 36 Denmark Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 37 Denmark Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 38 Denmark Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 39 Sweden Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 40 Sweden Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 41 Sweden Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 42 Norway Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 43 Norway Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 44 Norway Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Iron Deficiency Anemia Therapy market, by country, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 49 Japan Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 50 Japan Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 51 Japan Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 52 China Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 53 China Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 54 China Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 55 India Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 56 India Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 57 India Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 58 Australia Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 59 Australia Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 60 Australia Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 61 Thailand Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 62 Thailand Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 63 Thailand Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 64 South Korea Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 65 South Korea Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 66 South Korea Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 67 Latin America Iron Deficiency Anemia Therapy market, by country, 2018 - 2030 (USD Million)
Table 68 Latin America Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 69 Latin America Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 70 Latin America Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 71 Brazil Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 72 Brazil Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 73 Brazil Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 74 Mexico Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 75 Mexico Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 76 Mexico Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 77 Argentina Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 78 Argentina Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 79 Argentina Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa Iron Deficiency Anemia Therapy market, by country, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 84 South Africa Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 85 South Africa Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 86 South Africa Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 90 UAE Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 91 UAE Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 92 UAE Iron Deficiency Anemia Therapy market, by End-User, 2018 - 2030 (USD Million)
Table 93 Kuwait Iron Deficiency Anemia Therapy market, by Therapy Type, 2018 - 2030 (USD Million)
Table 94 Kuwait Iron Deficiency Anemia Therapy market, by Age Group, 2018 - 2030 (USD Million)
Table 95 Kuwait Iron Deficiency Anemia Therapy market, by End-User, 2018-2030, (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Iron deficiency anemia therapy, market segmentation
Fig. 8 Market snapshot, 2022
Fig. 9 Market Trends & Outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 Market challenge relevance analysis (current & future impact)
Fig. 13 SWOT analysis
Fig. 14 Porter’s five forces analysis
Fig. 15 Global iron deficiency anemia therapy market: Therapy Type movement & market share analysis
Fig. 16 Global iron deficiency anemia therapy market, for oral iron therapy, 2018 - 2030 (USD Million)
Fig. 17 Global iron deficiency anemia therapy market, for parenteral iron therapy, 2018 - 2030 (USD Million)
Fig. 18 Global iron deficiency anemia therapy market, for red blood cell transfusion, 2018 - 2030 (USD Million)
Fig. 19 Global iron deficiency anemia therapy market, for other therapies, 2018 - 2030 (USD Million)
Fig. 20 Global iron deficiency anemia therapy market: Age group movement & market share analysis
Fig. 21 Global iron deficiency anemia therapy market, for adults, 2018 - 2030 (USD Million)
Fig. 22 Global iron deficiency anemia therapy market, for pediatric, 2018 - 2030 (USD Million)
Fig. 23 Global iron deficiency anemia therapy market, for geriatric, 2018 - 2030 (USD Million)
Fig. 24 Global iron deficiency anemia therapy market: End-user movement & market share analysis
Fig. 25 Global iron deficiency anemia therapy market, for clinics, 2018 - 2030 (USD Million)
Fig. 26 Global iron deficiency anemia therapy market, for hospitals, 2018 - 2030 (USD Million)
Fig. 27 Global iron deficiency anemia therapy market, for home healthcare, 2018 - 2030 (USD Million)
Fig. 28 Regional marketplace: key takeaways
Fig. 29 Regional outlook, 2022 & 2030
Fig. 30 Global iron deficiency anemia therapy market: region movement analysis
Fig. 31 North America iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 32 US key country dynamics
Fig. 33 US iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 34 Canada key country dynamics
Fig. 35 Canada iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 36 Europe iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 37 UK key country dynamics
Fig. 38 UK iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 39 Germany key country dynamics
Fig. 40 Germany iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 41 France key country dynamics
Fig. 42 France iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 43 Italy key country dynamics
Fig. 44 Italy iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 45 Spain key country dynamics
Fig. 46 Spain iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 47 Denmark key country dynamics
Fig. 48 Denmark iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 49 Sweden key country dynamics
Fig. 50 Sweden iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 51 Norway key country dynamics
Fig. 52 Norway iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 53 Asia Pacific iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 54 Japan key country dynamics
Fig. 55 Japan iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 56 China key country dynamics
Fig. 57 China iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 58 India key country dynamics
Fig. 59 India iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 60 Australia key country dynamics
Fig. 61 Australia iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 62 Thailand key country dynamics
Fig. 63 Thailand iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 64 South Korea key country dynamics
Fig. 65 South Korea iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 66 Latin America iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 67 Brazil key country dynamics
Fig. 68 Brazil iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 69 Mexico key country dynamics
Fig. 70 Mexico iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 71 Argentina key country dynamics
Fig. 72 Argentina iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 73 Middle East and Africa iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 74 South Africa key country dynamics
Fig. 75 South Africa iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 76 Saudi Arabia key country dynamics
Fig. 77 Saudi Arabia iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 78 UAE key country dynamics
Fig. 79 UAE iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 80 Kuwait key country dynamics
Fig. 81 Kuwait iron deficiency anemia therapy market, 2018 - 2030 (USD Million)
Fig. 82 Company market position analysis
Fig. 83 Company/competition categorization
Fig. 84 Strategy mapping

★調査レポート[世界の鉄欠乏性貧血(IDA)治療市場(2023-2030):治療種類別(経口鉄剤治療、非経口鉄剤治療)、年齢層別、エンドユーザー別、地域別] (コード:GRV23NOV276)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の鉄欠乏性貧血(IDA)治療市場(2023-2030):治療種類別(経口鉄剤治療、非経口鉄剤治療)、年齢層別、エンドユーザー別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆